Cannara Biotech Inc. (LOVE.V)

CAD 1.42

(-1.39%)

Revenue Summary of Cannara Biotech Inc.

  • Cannara Biotech Inc.'s latest annual revenue in 2023 was 57.26 Million CAD , up 59.76% from previous year.
  • Cannara Biotech Inc.'s latest quarterly revenue in 2024 Q3 was 19.54 Million CAD , down -0.7% from previous quarter.
  • Cannara Biotech Inc. reported a annual revenue of 35.84 Million CAD in annual revenue 2022, up 110.58% from previous year.
  • Cannara Biotech Inc. reported a annual revenue of 17.02 Million CAD in annual revenue 2021, up 567.24% from previous year.
  • Cannara Biotech Inc. reported a quarterly revenue of 19.48 Million CAD for 2024 Q1, up 6.29% from previous quarter.
  • Cannara Biotech Inc. reported a quarterly revenue of 19.54 Million CAD for 2024 Q3, down -0.7% from previous quarter.

Annual Revenue Chart of Cannara Biotech Inc. (2023 - 2018)

Historical Annual Revenue of Cannara Biotech Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 57.26 Million CAD 59.76%
2022 35.84 Million CAD 110.58%
2021 17.02 Million CAD 567.24%
2020 2.55 Million CAD 21.64%
2019 2.09 Million CAD 384.7%
2018 432.63 Thousand CAD 0.0%

Peer Revenue Comparison of Cannara Biotech Inc.

Name Revenue Revenue Difference
Aequus Pharmaceuticals Inc. 254.89 Thousand CAD -22364.139%
CanadaBis Capital Inc. 22.22 Million CAD -157.668%
Decibel Cannabis Company Inc. 115.95 Million CAD 50.62%
Delivra Health Brands Inc. 12.37 Million CAD -362.596%
Entourage Health Corp. 40.71 Million CAD -40.644%
Lifeist Wellness Inc. 21.65 Million CAD -164.361%
Medicure Inc. 21.69 Million CAD -163.945%
PharmaCielo Ltd. 1.54 Million CAD -3613.976%
Rubicon Organics Inc. 40.11 Million CAD -42.735%
BioSyent Inc. 31.59 Million CAD -81.259%
Voyageur Pharmaceuticals Ltd. - CAD -Infinity%